Full reporting of Phase 1 clinical trial with HPH116 (50 heathly volunteers)
Full reporting of Phase 1 clinical trial Food Drug Interaction (12 healthly volunteers) Submission to the FDA of an IND request
Full reporting of Phase 1 clinical trial Food Drug Interaction (12 healthly volunteers)
Submission to the FDA of an IND request
Scientific Advisory Board Full reporting of six months toxicology study in rats
Scientific Advisory Board
Full reporting of six months toxicology study in rats
18 months stability report for Active Product Ingredient and Capsules Labima Laboratories collaboration
Meeting with Investagator Centers in Spain 600 mg capsules for clinical trial "Proof of Concept" Agreement of the Ethical Committees from the six centers in Spain
Meeting with Investagator Centers in Spain 600 mg capsules for clinical trial "Proof of Concept"
Agreement of the Ethical Committees from the six centers in Spain
Responses to Spanih Authorities Designation of a central laboratory for CD4 counts and Viral Load
EudraCT annual reporting on Adverse Evens Follow up Study “Proof of Concept”
Capital increase up to 8.3500.000€
Milestones 2008
24 months dog toxicology study
Phase I/II double blind study 36 patients 6 clinical center Spain
Phase I/II double blind study 36 patients
6 clinical center Spain
New shareholding GCP,GLP,GMP therapeutic vaccine preparation
New shareholding
GCP,GLP,GMP therapeutic vaccine preparation
Milestones 2009
Preparation of clinical phase II therapeutic vaccine New patent covering therapeutic vaccine applications
Preparation of clinical phase II therapeutic vaccine
New patent covering therapeutic vaccine applications
Milestones 2007
